Adma Biologics (ADMA) is down -12.6%, or -$1.43 to $9.90.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ADMA:
- Midday Fly By: Merck to acquire Terns, Arm CPU launch applauded
- Adma Biologics addresses misleading report by Culper Research
- Culper Research short Adma Biologics, says reported growth ‘a fiction’
- ADMA Biologics Launches Major 2026 Capital Return Plan
- Adma Biologics announces $125M accelerated share repurchase with JPMorgan